- Enhancement of protective immune responses by oral vaccination with Saccharomyces cerevisiae expressing recombinant Actinobacillus pleuropneumoniae ApxIA or ApxIIA in mice
-
Shin SJ, Shin SW, Kang ML, Lee DY, Yang MS, Jang YS, Yoo HS
- KMID: 1106219
- J Vet Sci.
- 2007 Dec;8(4):383-392.
- doi: 10.4142/jvs.2007.8.4.383
We previously induced protective immune response by oral immunization with yeast expressing the ApxIIA antigen. The ApxI antigen is also an important factor in the protection against Actinobacillus pleuropneumoniae serotype... -
- CITED
-
- Close
- SHARE
-
- Close
- Diet, microbiota, and inflammatory bowel disease: lessons from Japanese foods
-
Kanai T, Matsuoka K, Naganuma M, Hayashi A, Hisamatsu
- KMID: 2070102
- Korean J Intern Med.
- 2014 Jul;29(4):409-415.
The incidence and prevalence of inflammatory bowel diseases (IBDs) including ulcerative colitis and Crohn disease are rapidly increasing in Western countries and in developed Asian countries. Although biologic agents targeting... -
- CITED
-
- Close
- SHARE
-
- Close
- Expression of verocytotoxic Escherichia coli antigens in tobacco seeds and evaluation of gut immunity after oral administration in mouse model
-
Rossi L, Di Giancamillo A, Reggi S, Domeneghini C, Baldi A, Sala V, Dell'Orto , Coddens A, Cox E, Fogher C
- KMID: 1705556
- J Vet Sci.
- 2013 Sep;14(3):263-270.
- doi: 10.4142/jvs.2013.14.3.263
Verocytotoxic Escherichia (E.) coli strains are responsible for swine oedema disease, which is an enterotoxaemia that causes economic losses in the pig industry. The production of a vaccine for oral... -
- CITED
-
- Close
- SHARE
-
- Close
